Q&A: Understanding integration site analysis and genotox... Jordan Ruggieri, MBA
Read More Genotoxicity, vectors, and the power of integration site analysis

Q&A: Understanding integration site analysis and genotox... Jordan Ruggieri, MBA by / 06.23.2026
Read More Genotoxicity, vectors, and the power of integration site analysis
What controlled continuity means in practice From an operati... Dirk Leister by / 06.23.2026
Read More Reducing Discontinuities in Pharmaceutical Scale-Up
Liquid biopsy offers a powerful, noninvasive way to detect a... Deepak Tripathi, PhD by / 06.18.2026
Read More Improving the Reliability of Liquid Biopsy in Real-World Settings Through Workflow Standardization: A Discussion with Dr. Matteo Allegretti
FAQs... Dirk Leister by / 06.09.2026
Read More What Does Scale-Up Look Like When Volume is Not the Goal?
What is epigenetics and why does it matter? What are you stu... Jordan Ruggieri, MBA by / 05.28.2026
Read More Epigenetics unlocked: How behavior shapes biology
... Janam Pandya by / 05.19.2026
Read More What Happens to Your Raman Model When the Instrument Changes?
Chimeric Antigen Receptor (CAR) T cell therapy has transform... by Behind The Bench Staff / 05.16.2026
Read More Allogeneic cell therapies: Enhancing patient access via off-the-shelf options
What Are iPSCs and Why Do They Matter in Disease Modeling? W... Jordan Ruggieri, MBA by / 05.15.2026
Read More Finding the “Cheat Codes” to Cell Identity: Deterministic Programming of iPSCs
Why the 2026 Andes Virus Incident Matters Recent development... Geoffrey Cassell, PhD, MBA by / 05.14.2026
Read More Responding to Hantavirus: Advancing Rapid Molecular Detection